Involvement of the peripheral nervous system in primary Sjögren's syndrome.

BACKGROUND Involvement of the peripheral nervous system in patients with primary Sjögren's syndrome (SS) has been reported, but its prevalence in neurologically asymptomatic patients is not well known. OBJECTIVE To assess clinical and neurophysiological features of the peripheral nervous system in patients with primary SS. PATIENTS AND METHODS 39 (38 female) consecutive patients with primary SS, aged 20-81 years (mean 50), with a disease duration of 1-30 years (mean 8) were studied. The peripheral nervous system was evaluated by a questionnaire, physical examination, quantified sensory neurological examination, and neurophysiological measurements (nerve conduction studies). To assess autonomic cardiovascular function an orthostatic challenge test, a Valsalva manoeuvre, a forced respiration test, and pupillography were done. RESULTS Abnormalities as indicated in the questionnaire were found in 8/39 (21%) patients, while an abnormal neurological examination was found in 7/39 (18%) patients. Abnormalities in quantified sensory neurological examination were found in 22/38 (58%) patients. In 9/39 (23%) patients, neurophysiological signs compatible with a sensory polyneuropathy were found. No differences were found in the autonomic test results, disease duration, serological parameters, or erythrocyte sedimentation rate between the patients with primary SS with and those without evidence of peripheral nervous involvement. CONCLUSION Subclinical abnormalities of the peripheral nervous system may occur in patients with primary SS selected from a department of rheumatology, but clinically relevant involvement of the peripheral nervous system in this patient group is rare.

[1]  G. van der Heijde,et al.  Parasympathetic failure does not contribute to ocular dryness in primary Sjögren's syndrome , 1999, Annals of the rheumatic diseases.

[2]  J. Christodoulou,et al.  Autonomic cardiovascular neuropathy in Sjögren's syndrome. A controlled study. , 1998, The Journal of rheumatology.

[3]  A. J. Man in 't Veld,et al.  Primary Sjögren's syndrome presenting as autonomic neuropathy. Case report. , 1998, The Netherlands journal of medicine.

[4]  C. Morillas,et al.  Cardiovascular autonomic neuropathy in type 1 diabetic patients with and without peripheral neuropathy. , 1998, Diabetes research and clinical practice.

[5]  J. Berciano,et al.  High-dose IV immunoglobulin for peripheral neuropathy associated with Sjögren's syndrome , 1998, Neurology.

[6]  B. Richardson,et al.  Neurology of the vasculitides and connective tissue diseases , 1998, Journal of neurology, neurosurgery, and psychiatry.

[7]  M. Denišlič,et al.  Early asymmetric neuropathy in primary Sjögren’s syndrome , 1997, Journal of Neurology.

[8]  G. Hunder,et al.  Peripheral neuropathy associated with sicca complex , 1997, Neurology.

[9]  L. Jacobsson,et al.  Disturbances of autonomic nervous function in primary Sjögren's syndrome. , 1997, Scandinavian journal of rheumatology.

[10]  M. J. van den Bent,et al.  Peripheral neurotoxicity induced by docetaxel , 1996, Neurology.

[11]  M. Popović,et al.  Small nerve fibre dysfunction in a patient with Sjögren's syndrome. Neurophysiological and morphological confirmation. , 1995, Scandinavian journal of rheumatology.

[12]  G. Pavesi,et al.  Peripheral neuropathy associated with primary Sjögren's syndrome. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[13]  H. Kornhuber,et al.  Neurological and neuropsychiatric dysfunction in primary Sjögren's syndrome , 1994, Acta neurologica Scandinavica.

[14]  H. Moutsopoulos,et al.  Is central nervous system involvement a systemic manifestation of primary Sjögren's syndrome? , 1993, Rheumatic diseases clinics of North America.

[15]  D. Isenberg,et al.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. , 1993, Arthritis and rheumatism.

[16]  M. Oudkerk,et al.  Digital subtraction sialography of the parotid glands in primary Sjögren's syndrome. , 1993, The Journal of rheumatology.

[17]  R. Lipton,et al.  Large and small fibre type sensory dysfunction in patients with cancer. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[18]  M. Raschke,et al.  Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin-dependent) diabetes. , 1991, The Journal of diabetic complications.

[19]  A. Drosos,et al.  The spectrum of neurological involvement in Sjögren's syndrome. , 1990, British journal of rheumatology.

[20]  A. Hietaharju,et al.  Nervous system manifestations in Sjögren's syndrome , 1990, Acta neurologica Scandinavica.

[21]  R. Hoop,et al.  Vibration perception and thermoperception as quantitative measurements in the monitoring of cisplatin induced neurotoxicity , 1989, Journal of the Neurological Sciences.

[22]  D. Isenberg,et al.  Sjögren's syndrome: a study of its neurological complications. , 1988, British journal of rheumatology.

[23]  E. Alexander,et al.  Sjögren's syndrome. Cutaneous, immunologic, and nervous system manifestations. , 1987, Neurologic clinics.

[24]  G. Jamal,et al.  Thermal discrimination thresholds in normal subjects and in patients with diabetic neuropathy. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[25]  J. Peyronnard,et al.  Vasculitic neuropathy in rheumatoid disease and Sjögren syndrome , 1982, Neurology.

[26]  J. Goldberg,et al.  Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation. , 1979, Journal of neurology, neurosurgery, and psychiatry.

[27]  H. S. Davis,et al.  A Controlled Study , 1966 .